Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertonic saline versus mannitol for intracranial pressure reduction during supratentorial tumor surgery
ACTRN12616000655448Phase 4Completed
- Sponsor
- achmet ali
- Start
- May 2016
- Modality
- Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in intracranial hypertension (IH) and brain neoplasm comparing Mannitol group with Hypertonic saline group (2 arms). Primary endpoint: Change in intracranial pressure. Started May 2016; status: completed.
02
Drugs
Bronchitolhypertonic saline
03
Conditions
intracranial hypertension (IH)brain neoplasm
Beyond the preview
Go deeper on ACTRN12616000655448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000655448.